By using advanced mapping technologies, scientists have created a detailed “atlas” of stomach tumors, revealing hidden ...

A team of Singapore scientists has made a significant discovery in understanding stomach cancer, a disease that remains one ...

Stomach cancer rates in the United States have been steadily decreasing for decades, but recent trends reveal an increase in early-onset stomach cancer in people younger than 50, particularly women.

Scientists identify mutation patterns in healthy stomach lining, offering new insights into the earliest steps of cancer ...

When combined with trastuzumab and chemotherapy, treatment with pembrolizumab was associated with a statistically significant improvement in PFS and OS compared with placebo.

For the first time, scientists have systematically analyzed somatic mutations in stomach lining tissue to unpick mutational ...

A team of Singapore scientists has made a significant discovery in understanding stomach cancer, a disease that remains one ...

Leap Therapeutics' Phase 2 trial data show sirexatamab boosts response rates and survival in MSS colorectal cancer, with ...

The FDA granted orphan drug designation to HLX22 for gastric cancer, advancing global phase 3 trials to improve first-line ...

The study found that gastric cells in some individuals carried three copies of certain chromosomes, hinting toward exposure ...

The FDA has approved Tevimbra with chemotherapy for the first-line treatment of unresectable or metastatic ESCC whose tumors express PD-L1.